BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 29568059)

  • 41. Circ008913, via miR-889 regulation of DAB2IP/ZEB1, is involved in the arsenite-induced acquisition of CSC-like properties by human keratinocytes in carcinogenesis.
    Xiao T; Xue J; Shi M; Chen C; Luo F; Xu H; Chen X; Sun B; Sun Q; Yang Q; Dai X; Zhang A; Tang H; Liu Q
    Metallomics; 2018 Sep; 10(9):1328-1338. PubMed ID: 30167605
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Infiltrating T cells promote renal cell carcinoma (RCC) progression via altering the estrogen receptor β-DAB2IP signals.
    Yeh CR; Ou ZY; Xiao GQ; Guancial E; Yeh S
    Oncotarget; 2015 Dec; 6(42):44346-59. PubMed ID: 26587829
    [TBL] [Abstract][Full Text] [Related]  

  • 43. DAB2IP Is a Bifunctional Tumor Suppressor That Regulates Wild-Type RAS and Inflammatory Cascades in KRAS Mutant Colon Cancer.
    Miller AL; Perurena N; Gardner A; Hinoue T; Loi P; Laird PW; Cichowski K
    Cancer Res; 2023 Jun; 83(11):1800-1814. PubMed ID: 36939385
    [TBL] [Abstract][Full Text] [Related]  

  • 44. MicroRNA-656-3p inhibits colorectal cancer cell migration, invasion, and chemo-resistance by targeting sphingosine-1-phosphate phosphatase 1.
    Zhang B; Gao S; Bao Z; Pan C; Tian Q; Tang Q
    Bioengineered; 2022 Feb; 13(2):3810-3826. PubMed ID: 35081855
    [TBL] [Abstract][Full Text] [Related]  

  • 45. MiR-1266 promotes cell proliferation, migration and invasion in cervical cancer by targeting DAB2IP.
    Wang J; Liu Y; Wang X; Li J; Wei J; Wang Y; Song W; Zhang Z
    Biochim Biophys Acta Mol Basis Dis; 2018 Dec; 1864(12):3623-3630. PubMed ID: 30261286
    [TBL] [Abstract][Full Text] [Related]  

  • 46. An oncogene-tumor suppressor cascade drives metastatic prostate cancer by coordinately activating Ras and nuclear factor-kappaB.
    Min J; Zaslavsky A; Fedele G; McLaughlin SK; Reczek EE; De Raedt T; Guney I; Strochlic DE; Macconaill LE; Beroukhim R; Bronson RT; Ryeom S; Hahn WC; Loda M; Cichowski K
    Nat Med; 2010 Mar; 16(3):286-94. PubMed ID: 20154697
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The RNA-binding protein HuR opposes the repression of ERBB-2 gene expression by microRNA miR-331-3p in prostate cancer cells.
    Epis MR; Barker A; Giles KM; Beveridge DJ; Leedman PJ
    J Biol Chem; 2011 Dec; 286(48):41442-41454. PubMed ID: 21971048
    [TBL] [Abstract][Full Text] [Related]  

  • 48. miR-330-3p promotes lung cancer cells invasion, migration, and metastasis by directly targeting hSOD2b.
    Shen L; Yi S; Huang L; Li S; Bai F; Lei S; Breitzig M; Czachor A; Sun H; Zheng Q; Wang F
    Biotechnol Appl Biochem; 2019 Jan; 66(1):21-32. PubMed ID: 30192404
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Two GEO MicroRNA Expression Profile Based High-Throughput Screen to Identify MicroRNA-31-3p Regulating Growth of Medullary Thyroid Carcinoma Cell by Targeting RASA2.
    Jiang M; Shi X; Zhu H; Wei W; Li J
    Med Sci Monit; 2019 Jul; 25():5170-5180. PubMed ID: 31298226
    [TBL] [Abstract][Full Text] [Related]  

  • 50. MicroRNA-450b-3p inhibits cell growth by targeting phosphoglycerate kinase 1 in hepatocellular carcinoma.
    Chen Z; Zhuang W; Wang Z; Xiao W; Don W; Li X; Chen X
    J Cell Biochem; 2019 Nov; 120(11):18805-18815. PubMed ID: 31222833
    [TBL] [Abstract][Full Text] [Related]  

  • 51. LINC00240 promotes gastric cancer cell proliferation, migration and EMT via the miR-124-3p / DNMT3B axis.
    Li Y; Yan J; Wang Y; Wang C; Zhang C; Li G
    Cell Biochem Funct; 2020 Dec; 38(8):1079-1088. PubMed ID: 32526811
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Decreased DAB2IP gene expression, which could be induced by fractionated irradiation, is associated with resistance to γ‑rays and α‑particles in prostate cancer cells.
    Yang C; He H; Zhang T; Chen Y; Kong Z
    Mol Med Rep; 2016 Jul; 14(1):567-73. PubMed ID: 27177018
    [TBL] [Abstract][Full Text] [Related]  

  • 53. DAB2IP in cancer.
    Liu L; Xu C; Hsieh JT; Gong J; Xie D
    Oncotarget; 2016 Jan; 7(4):3766-76. PubMed ID: 26658103
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Methylation-associated miR-193b silencing activates master drivers of aggressive prostate cancer.
    Mazzu YZ; Yoshikawa Y; Nandakumar S; Chakraborty G; Armenia J; Jehane LE; Lee GM; Kantoff PW
    Mol Oncol; 2019 Sep; 13(9):1944-1958. PubMed ID: 31225930
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Epothilone B confers radiation dose enhancement in DAB2IP gene knock-down radioresistant prostate cancer cells.
    Kong Z; Raghavan P; Xie D; Boike T; Burma S; Chen D; Chakraborty A; Hsieh JT; Saha D
    Int J Radiat Oncol Biol Phys; 2010 Nov; 78(4):1210-8. PubMed ID: 20970033
    [TBL] [Abstract][Full Text] [Related]  

  • 56. miR-431 Promotes Metastasis of Pancreatic Neuroendocrine Tumors by Targeting DAB2 Interacting Protein, a Ras GTPase Activating Protein Tumor Suppressor.
    Zhang T; Choi S; Zhang T; Chen Z; Chi Y; Huang S; Xiang JZ; Du YN
    Am J Pathol; 2020 Mar; 190(3):689-701. PubMed ID: 31953039
    [TBL] [Abstract][Full Text] [Related]  

  • 57. DAB2IP coordinates both PI3K-Akt and ASK1 pathways for cell survival and apoptosis.
    Xie D; Gore C; Zhou J; Pong RC; Zhang H; Yu L; Vessella RL; Min W; Hsieh JT
    Proc Natl Acad Sci U S A; 2009 Nov; 106(47):19878-83. PubMed ID: 19903888
    [TBL] [Abstract][Full Text] [Related]  

  • 58. DOC-2/DAB2 interactive protein regulates proliferation and mobility of nasopharyngeal carcinoma cells by targeting PI3K/Akt pathway.
    Wang B; Gu Q; Li J
    Oncol Rep; 2017 Jul; 38(1):317-324. PubMed ID: 28586035
    [TBL] [Abstract][Full Text] [Related]  

  • 59. miR-135a Inhibits the Invasion of Cancer Cells via Suppression of ERRα.
    Tribollet V; Barenton B; Kroiss A; Vincent S; Zhang L; Forcet C; Cerutti C; Périan S; Allioli N; Samarut J; Vanacker JM
    PLoS One; 2016; 11(5):e0156445. PubMed ID: 27227989
    [TBL] [Abstract][Full Text] [Related]  

  • 60. MicroRNA-494-3p targets CXCR4 to suppress the proliferation, invasion, and migration of prostate cancer.
    Shen PF; Chen XQ; Liao YC; Chen N; Zhou Q; Wei Q; Li X; Wang J; Zeng H
    Prostate; 2014 May; 74(7):756-67. PubMed ID: 24644030
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.